Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1948 1
1949 1
1950 1
1951 3
1953 2
1954 2
1955 1
1956 3
1957 2
1958 5
1959 4
1960 1
1961 3
1962 3
1963 8
1964 5
1965 5
1966 12
1967 10
1968 9
1969 9
1970 3
1971 13
1972 7
1973 13
1974 14
1975 5
1976 9
1977 6
1978 10
1979 7
1980 13
1981 14
1982 15
1983 15
1984 25
1985 28
1986 18
1987 37
1988 41
1989 46
1990 41
1991 49
1992 61
1993 53
1994 66
1995 68
1996 80
1997 91
1998 89
1999 99
2000 110
2001 105
2002 128
2003 112
2004 123
2005 149
2006 153
2007 160
2008 194
2009 185
2010 188
2011 229
2012 237
2013 243
2014 251
2015 261
2016 246
2017 212
2018 256
2019 232
2020 276
2021 292
2022 259
2023 275
2024 289
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,688 results

Results by year

Filters applied: . Clear all
Page 1
Adipo-glial signaling mediates metabolic adaptation in peripheral nerve regeneration.
Sundaram VK, Schütza V, Schröter NH, Backhaus A, Bilsing A, Joneck L, Seelbach A, Mutschler C, Gomez-Sanchez JA, Schäffner E, Sánchez EE, Akkermann D, Paul C, Schwagarus N, Müller S, Odle A, Childs G, Ewers D, Kungl T, Sitte M, Salinas G, Sereda MW, Nave KA, Schwab MH, Ost M, Arthur-Farraj P, Stassart RM, Fledrich R. Sundaram VK, et al. Among authors: muller s. Cell Metab. 2023 Dec 5;35(12):2136-2152.e9. doi: 10.1016/j.cmet.2023.10.017. Epub 2023 Nov 20. Cell Metab. 2023. PMID: 37989315 Free PMC article.
Chronic Prurigo.
Thünemann J, Müller S, Steinbrink K, Ständer S, Zeidler C. Thünemann J, et al. Among authors: muller s. J Dtsch Dermatol Ges. 2024 Jun;22(6):813-823. doi: 10.1111/ddg.15317. Epub 2024 May 9. J Dtsch Dermatol Ges. 2024. PMID: 38722190 Review.
Reactivated endogenous retroviruses promote protein aggregate spreading.
Liu S, Heumüller SE, Hossinger A, Müller SA, Buravlova O, Lichtenthaler SF, Denner P, Vorberg IM. Liu S, et al. Among authors: muller sa. Nat Commun. 2023 Aug 18;14(1):5034. doi: 10.1038/s41467-023-40632-z. Nat Commun. 2023. PMID: 37596282 Free PMC article.
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Meier S, Willemse EAJ, Schaedelin S, Oechtering J, Lorscheider J, Melie-Garcia L, Cagol A, Barakovic M, Galbusera R, Subramaniam S, Barro C, Abdelhak A, Thebault S, Achtnichts L, Lalive P, Müller S, Pot C, Salmen A, Disanto G, Zecca C, D'Souza M, Orleth A, Khalil M, Buchmann A, Du Pasquier R, Yaldizli Ö, Derfuss T, Berger K, Hermesdorf M, Wiendl H, Piehl F, Battaglini M, Fischer U, Kappos L, Gobbi C, Granziera C, Bridel C, Leppert D, Maleska Maceski A, Benkert P, Kuhle J. Meier S, et al. Among authors: muller s. JAMA Neurol. 2023 Mar 1;80(3):287-297. doi: 10.1001/jamaneurol.2022.5250. JAMA Neurol. 2023. PMID: 36745446 Free PMC article.
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
Heinemann V, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Hielscher J, Scholz M, Müller S, Link H, Niederle N, Rost A, Höffkes HG, Moehler M, Lindig RU, Modest DP, Rossius L, Kirchner T, Jung A, Stintzing S. Heinemann V, et al. Among authors: muller s. Lancet Oncol. 2014 Sep;15(10):1065-75. doi: 10.1016/S1470-2045(14)70330-4. Epub 2014 Jul 31. Lancet Oncol. 2014. PMID: 25088940 Clinical Trial.
Quelles actions pour lutter contre la désinformation sur les produits de santé ?
Micallef J, Maisonneuve H, Muller S, Molimard M, Bégaud B, Cabut S, Daban M, Drici MD, Gatignol C, Grumblat A, Guaspare-Cartron C, Lasserre B, Mebarki A, Pons C, Prabonnaud F, Raynaud C, Saint-Lary O. Micallef J, et al. Among authors: muller s. Therapie. 2024 Jan-Feb;79(1):75-86. doi: 10.1016/j.therap.2023.10.004. Epub 2023 Oct 29. Therapie. 2024. PMID: 37985308 French. No abstract available.
EuroGuiderm guideline on lichen sclerosus-Treatment of lichen sclerosus.
Kirtschig G, Kinberger M, Kreuter A, Simpson R, Günthert A, van Hees C, Becker K, Ramakers MJ, Corazza M, Müller S, von Seitzberg S, Boffa MJ, Stein R, Barbagli G, Chi CC, Dauendorffer JN, Fischer B, Gaskins M, Hiltunen-Back E, Höfinger A, Köllmann NH, Kühn H, Larsen HK, Lazzeri M, Mendling W, Nikkels AF, Promm M, Rall KK, Regauer S, Sárdy M, Sepp N, Thune T, Tsiogka A, Vassileva S, Voswinkel L, Wölber L, Werner RN. Kirtschig G, et al. Among authors: muller s. J Eur Acad Dermatol Venereol. 2024 Oct;38(10):1874-1909. doi: 10.1111/jdv.20083. Epub 2024 Jun 1. J Eur Acad Dermatol Venereol. 2024. PMID: 38822598
5,688 results